Marseille, November 13, 2024 – Marseille Immunology Biocluster (MIB) today announced its deployment following the agreement with the Agence Nationale de la Recherche, in the presence of Christophe Mirmand, Prefect of the Provence-Alpes-Côte d’Azur region, Renaud Muselier, President of the Provence-Alpes-Côte d’Azur region, President Delegate of Régions de France, Emmanuelle Charafe, Vice-President of the Metropole, and Dr. Lise Alter, Managing Director of the Agence de l’innovation en santé.

The Marseille Immunology Biocluster project was born of an alliance of private and public sector players in partnership with local authorities, and in 2023 was one of the five winners of the Biocluster call for projects under the Innovation santé 2030 plan, the health component of France 2030, launched in 2022 to boost France’s attractiveness as a land of innovation and research in cutting-edge fields, particularly in the healthcare sector. The aim of the MIB project is to contribute to French sovereignty in the healthcare field, and in particular in immunotherapy, which holds great promise for patients waiting for therapeutic answers.